JNCE

Jounce Therapeutics, Inc. Common Stock

Delisted

JNCE was delisted on the 3rd of May, 2023.

102 hedge funds and large institutions have $207M invested in Jounce Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 21 increasing their positions, 40 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
102
Holders Change
+12
Holders Change %
+13.33%
% of All Funds
2.06%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
24
Increased
21
Reduced
40
Closed
12
Calls
$1.72M
Puts
$1.54M
Net Calls
+$179K
Net Calls Change
-$332K
Name Holding Trade Value Shares
Change
Shares
Change %
Massachusetts Financial Services
101
Massachusetts Financial Services
Massachusetts
-$1.08M -156,631 Closed
Los Angeles Capital Management
102
Los Angeles Capital Management
California
-$638K -92,420 Closed
Marshall Wace
103
Marshall Wace
United Kingdom
-$582K -84,369 Closed
SFM
104
Systematic Financial Management
New Jersey
-$250K -36,265 Closed
BCM
105
Bridgeway Capital Management
Texas
-$216K -31,300 Closed
AG
106
Algert Global
California
-$187K -27,090 Closed
Two Sigma Advisers
107
Two Sigma Advisers
New York
-$175K -25,300 Closed
D.E. Shaw & Co
108
D.E. Shaw & Co
New York
-$168K -24,367 Closed
HS
109
HighVista Strategies
Massachusetts
-$104K -15,000 Closed
ECM
110
ExodusPoint Capital Management
New York
-$95K -13,738 Closed
Group One Trading
111
Group One Trading
Illinois
-$26K -3,760 Closed
RWB
112
RMR Wealth Builders
New Jersey
-$7K -1,000 Closed